In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture.
The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.
TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.
The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr., Ph.D., professor of microbiology & immunology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences.
Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol. “We hypothesized that TB bacteria that can’t make mycothiol might contain more cysteine, an amino acid,” said Dr. Jacobs. “So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected.”
The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a “reducing agent” that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.
“To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C,” said Dr. Jacobs. “The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains.”
To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.
“We don’t know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial,” said Dr. Jacobs. “It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB.”
The Latest Bing News on:
Drug-Resistant TB
- American Farms Have a Drug Problemon May 17, 2024 at 3:00 am
The growing risk from drug-resistant bacteria, fungi, viruses, and parasites, England’s former chief medical officer Sally Davies told The Guardian in an interview published this week, is “more acute” ...
- Aggressive contact tracing key to fight TB: Health officialon May 17, 2024 at 2:57 am
The Ministry of Health highlighted the need to step up contact investigation as part of the efforts to realize the target of eliminating tuberculosis (TB) by ...
- Experts developing immune-enhancing therapies to treat TB: Studyon May 16, 2024 at 8:24 pm
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug-resistant strains of the ...
- New national strategy to end tuberculosison May 16, 2024 at 7:19 am
The government recently launched the Striving to End Tuberculosis – A Strategy for Ireland 2024 – 2030. The strategy progresses the fight against tuberculosis (TB) and outlines the priorities, ...
- Govt hospitals run out of stock, patients scramble for TB drugson May 15, 2024 at 3:45 pm
Government hospitals in Noida and Ghaziabad are experiencing a shortage of anti-tuberculosis treatment medication, leading to patients scrambling to find essential TB drugs. The districts have over 22 ...
- Opinion: UNGA should address TB and antimicrobial resistance togetheron May 15, 2024 at 8:33 am
Drug-resistant tuberculosis, which is spread through air and responsible for a large number of deaths, is part of antimicrobial resistance efforts. The United Nations General Assembly can pave the way ...
- Africa: MSF Reveals Cost of Landmark TB Clinical Trial in Push for Drug-Development Cost Transparencyon May 15, 2024 at 7:10 am
Press Release - At the fifth WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Médecins Sans Frontières (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that ...
- ICMR releases Generic Concordance Study Protocol for assessing TB detection technologieson May 14, 2024 at 7:31 pm
ICMR releases Generic Concordance Study Protocol for assessing TB detection technologies: Shardul Nautiyal, Mumbai Wednesday, May 15, 2024, 08:00 Hrs [IST] The Indian Council of M ...
- Sketchy stem-cell treatments in Mexico led to drug-resistant infectionson May 13, 2024 at 2:26 pm
Three U.S. hospital patients contracted drug-resistant infections in Mexico in 2022 and were still being treated as of March 2024.
- What to know about TB after outbreak in Long Beach sickens 14on May 8, 2024 at 3:59 pm
A tuberculosis outbreak in Long Beach, California, has left 14 people sickened and one person dead. Here's everything you need to know about the illness.
The Latest Google Headlines on:
Drug-Resistant TB
[google_news title=”” keyword=”Drug-Resistant TB” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Tuberculosis
- Confirmed Case Of Tuberculosis At Chester High Schoolon May 17, 2024 at 7:56 am
South Carolina health officials are investigating a case of tuberculosis that has been confirmed at Chester High School.
- New national strategy to end tuberculosison May 16, 2024 at 7:19 am
The government recently launched the Striving to End Tuberculosis – A Strategy for Ireland 2024 – 2030. The strategy progresses the fight against tuberculosis (TB) and outlines the priorities, objectives,
The Latest Google Headlines on:
Tuberculosis
[google_news title=”” keyword=”tuberculosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]